AnagnosTec Gesellschaft für Company Profile

03:02 EDT 23rd September 2018 | BioPortfolio

AnagnosTec was founded in 1998 as a spin-off from the University of Technology, Berlin. The company offers services, contract research and products for bioanalytical applications based on MALDI-TOF Mass Spectrometry.The research at AnagnosTec is mainly focused on the development of novel mass spectrometric techniques in the fields of biotechnology, clinical medicine, microbiology, food industry and on the development of intelligent software solutions to handle and interpret mass spectrometric data.AnagnosTec's staff currently consists of 10 employees. Among our latest products are a new rapid technique for the direct analysis of secondary metabolites from unfractionated cells or tissue probes, as well as the determination of molecular masses and structure elucidation using Post Source Decay (PSD). Other recent applications include the rapid characterisation and classification of whole microorganisms by Intact-Cell-MALDI-TOF Mass Spectrometry. Anagnostec's SARAMIS system analyses MALDI-TOF fingerprint mass spectra to identify the microorganism with the best database match. The dendrogram feature classifies unknown isolates into a taxonomic tree and dereplicates duplicate strains simultaneously to improve drug discovery processes. Large microbial strain collections can be screened in high-troughput by using an in-house-built biohandling robot designed to pick microbial colonies from agar plates and to transfer the biomass to the MALDI target plate.


Analytische Biochemie & Diagnostik mbHIm Biotechnologiepark, TGZ II



Phone: 49 3371 68 11 26
Fax: 49 3371 68 11 27

News Articles [45 Associated News Articles listed on BioPortfolio]

Loving the sweet enemy

(Max-Planck-Gesellschaft) Foods rich in fats and carbohydrates stimulate the reward system in the brain particularly strongly.

The evolution of testes

(Max-Planck-Gesellschaft) Molecular vestiges resolve the controversial evolution of the testicular position in mammals.

One step closer to reality

(Max-Planck-Gesellschaft) The software 'PyFRAP' is an accurate and reliable tool for the analysis of molecular movement, employing numerical simulations rather than simplified assumptions.

Scientists discover how protein molecules regulate formation of myelin sheaths

According to the Deutsche Multiple Sklerose Gesellschaft, around 200,000 people in Germany suffer from multiple sclerosis- a serious neurological condition that has no known cure.

Brain: Modell vor Überarbeitung

Die Analysten von Baader bestätigen die Kaufempfehlung für die Aktien von Brain. Das Kursziel für die Papiere von Brain sehen die Experten weiter bei 24,00 Euro. Die Gesellschaft will die Mehrheit ...

Morphosys: Positives Feedback

Die Analysten der Commerzbank erneuern die Kaufempfehlung für die Aktien von Morphosys. Das Kursziel wird ebenso bestätigt. Es liegt für die Papiere von Morphosys bei 98,00 Euro. Die Gesellschaft h...

MORPHOSYS IM FOKUS: Vorschusslorbeeren für das erste eigene Medikament

Das Biotechunternehmen Morphosys steuert auf eine ernstzunehmende Karriere als Wirkstoffhersteller zu. Lange hatte sich die Gesellschaft als Auftragsforscher für andere Pharmaunternehmen im Markt ...

Morphosys plant Gang an die US-Börse - wann kommt das große Kaufsignal?

Das im TecDAX gehandelte Biotechunternehmen Morphosys macht sich startklar für den Gang an die US-Börse. Die Gesellschaft hat bei der amerikanischen Börsenaufsichtsbehörde SEC (U.S. Securities and...

Drugs and Medications [0 Results]


PubMed Articles [178 Associated PubMed Articles listed on BioPortfolio]

From Global Health Challenges to Community-Based and Individual Psychosocial Intervention Strategies.

Liebe Kolleginnen und Kollegen,wir freuen uns, Sie im Namen beider Fachgesellschaften und des Leipziger Kongressteams zur gemeinsamen Jahrestagung der Deutschen Gesellschaft für Medizinische Psycholo...

Biomechanics in ophthalmology.

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)

The purpose of this study is to collect information of the risk profile of patients with type 2 diabetes mellitus, their treatment concerning meeting the guidelines for treatment of diabet...

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (E...

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

To investigate and compare the efficacy, safety and tolerability of ziprasidone versus placebo in the treatment of conduct disorder (CD), oppositional defiant disorder (ODD) and disruptive...

Effects of Empagliflozin Plus Linagliptin vs Metformin Plus Insulin Glargin on Renal and Vascular Changes in Type 2 Diabetes

Diabetes mellitus is a wide-spread disease accompanied by strongly increased morbidity and mortality due to micro- and macrovascular complications. However, in studies with patients suffer...

Youth FORWARD Phase 1 YRI and EPP Study

Objectives: The objectives of this research proposal are to study the delivery of an evidence-based mental health intervention in the alternate setting of youth employment programs tied to...

Companies [17 Associated Companies listed on BioPortfolio]

AnagnosTec Gesellschaft für

AnagnosTec was founded in 1998 as a spin-off from the University of Technology, Berlin. The company offers services, contract research and products for bioanalytical applications based on MALDI-TOF Ma...


ICHTHYOL-GESELLSCHAFT, our independent, family-run pharmaceutical company became one of the most important suppliers of therapeutics in dermatology and orthopedics due to active ingredients of high gr...

Gesellschaft für Toxikologie (GT)


Gesellschaft Deutscher Chemiker



The Fraunhofer-Gesellschaft undertakes applied research of direct utility to private and public enterprise and of wide benefit to society. Its services are solicited by customers and contractual partn...

More Information about "AnagnosTec Gesellschaft für" on BioPortfolio

We have published hundreds of AnagnosTec Gesellschaft für news stories on BioPortfolio along with dozens of AnagnosTec Gesellschaft für Clinical Trials and PubMed Articles about AnagnosTec Gesellschaft für for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AnagnosTec Gesellschaft für Companies in our database. You can also find out about relevant AnagnosTec Gesellschaft für Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Corporate Database Quicklinks

Searches Linking to this Company Record